drugset / Trial / NCT00037674
A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
This primary purpose of this study is to evaluate the safety and efficacy of topiramate compared with lithium or placebo in the treatment of acute manic or mixed episodes in patients with Bipolar I Disorder.
Timeline
- Start
- 2001-01
- Primary completion
- —
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 200 mg | Oral |
| Subject | Topiramate | Small molecule | 400 mg | Oral |